THE WHAT? Walgreens Boots Alliance has introduced its outcomes for the second quarter of fiscal 2025. The drug retailer conglomerate mentioned that gross sales elevated 4.1 p.c year-on-year to US$38.6 billion and loss per share narrowed to US$3.30 in comparison with US$6.85 within the year-ago quarter.
THE DETAILS Nonetheless, adjusted EPS was US$0.63 in comparison with US$1.20 in the identical interval final yr, which WBA attributed to the prior yr adjusted efficient tax profit, decrease retail gross sales and prior-year sale leaseback good points.
The corporate is withdrawing fiscal 2025 steering in gentle of the actual fact it’s to be acquired by entities affiliated with Sycamore Companions.
THE WHY? Chief Govt Officer Tim Wentworth, reveals, “Second quarter outcomes replicate disciplined price administration and enchancment in US Healthcare, which had been partially offset by weaker front-end ends in US Retail Pharmacy, whereas important authorized settlements resulted in continued unfavourable free money circulation. We stay within the early phases of our turnaround plan, and proceed to anticipate that significant worth creation will take time, enhanced focus and balancing future money wants with vital investments to navigate a altering pharmacy and retail panorama.”
